tiprankstipranks
Advertisement
Advertisement
ShiraTronics Targets Chronic Migraine Dialogue at 2026 AAN Neurology Meeting
PremiumPrivate CompaniesShiraTronics Targets Chronic Migraine Dialogue at 2026 AAN Neurology Meeting
17d ago
ShiraTronics Targets Unmet Need in Chronic Migraine With Complementary Neuromodulation Strategy
Premium
Private Companies
ShiraTronics Targets Unmet Need in Chronic Migraine With Complementary Neuromodulation Strategy
29d ago
ShiraTronics Emphasizes Unmet Need in Chronic Migraine and Role for Neuromodulation
Premium
Private Companies
ShiraTronics Emphasizes Unmet Need in Chronic Migraine and Role for Neuromodulation
1M ago
ShiraTronics Highlights Hidden Workplace and Chronic Migraine Burden to Bolster Market Position
PremiumPrivate CompaniesShiraTronics Highlights Hidden Workplace and Chronic Migraine Burden to Bolster Market Position
2M ago
Workplace Migraine Burden Underscores Market Potential for ShiraTronics
Premium
Private Companies
Workplace Migraine Burden Underscores Market Potential for ShiraTronics
2M ago
Migraine Burden in the Workplace Underscores Market Potential for ShiraTronics
Premium
Private Companies
Migraine Burden in the Workplace Underscores Market Potential for ShiraTronics
2M ago
ShiraTronics Highlights Participation in 2026 NANS Meeting as It Advances Investigational Neuromodulation Therapy
PremiumPrivate CompaniesShiraTronics Highlights Participation in 2026 NANS Meeting as It Advances Investigational Neuromodulation Therapy
3M ago
ShiraTronics Highlights Ongoing Development of Investigational Neuromodulation Device for Chronic Migraine
Premium
Private Companies
ShiraTronics Highlights Ongoing Development of Investigational Neuromodulation Device for Chronic Migraine
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100